To recommend suitable NTRK gene fusion tests and to provide treatment suggestions based on the needs of particular patients, our group additionally classified cancer into three types: (1) whether or not NGS is commonly performed, (2) whether or not the TRK protein is physiologically expressed, and (3) whether or not NTRK gene fusions are prevalent (Table 3). Here, TPM3 is linked to cancer.